Isobel Williams

Dr. Isobel Williams


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

29 December 2020 in Cognitive Neuropsychiatry
Verified
Journal Article
Closed access
IWIsobel Williams
Isobel Williams
MRMarkus Reuber
Markus Reuber
LLLiat Levita
Liat Levita
Research suggests that patients with Functional Neurological Symptom Disorder (pwFND) struggle to identify their own emotions and associated physiological cues (interoceptive sensitivity, IS). Howe...

26 August 2019 in British Journal of Health Psychology
Verified
Journal Article
Closed access
PDF file
Nicolò ZarottiNicolò Zarotti
Nicolò Zarotti
ECElizabeth Coates
Elizabeth Coates
AMAlex McGeachan
Alex McGeachan
IWIsobel Williams
Isobel Williams
DBDaniel Beever
Daniel Beever
OGon behalf of the HighCALS Study Group
on behalf of the HighCALS Study Group

1 August 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
MEMunira Essat
Munira Essat
RARachel Archer
Rachel Archer
IWIsobel Williams
Isobel Williams
NZNicolò Zarotti
Nicolò Zarotti
ECElizabeth Coates
Elizabeth Coates
CMChristopher McDermott
Christopher McDermott

25 January 2018 in Behavioural and Cognitive Psychotherapy
Verified
Journal Article
Closed access
PDF file
IWIsobel Williams
Isobel Williams
SHStephanie Howlett
Stephanie Howlett
LLLiat Levita
Liat Levita
MRMarkus Reuber
Markus Reuber
Background: Functional neurological symptoms (FNS) are considered non-volitional and often very disabling, but are not explainable by neurological disease or structural abnormalities. Brief Augmented Psychodynamic Interpersonal Therapy (BAPIT) was adapted to treat the putative emotion processing deficits thought to be central to FNS aetiology and maintenance. BAPIT for FNS has previously been shown to improve levels of distress and functioning, but it is unknown whether improvements on such measures correlate with changes in emotion processing ‒ which this treatment focuses on. Aim: To determine (a) whether the recently developed Emotional Processing Scale-25 can be used to demonstrate BAPIT-associated changes in patients with FNS, and (b) whether changes in the EPS-25 are associated with changes in previously validated outcome measures. Method: 44 patients with FNS completed questionnaires including the EPS-25 and measures of clinical symptomology (health-related quality of life (SF-36), somatic symptoms (PHQ-15), psychological distress (CORE-10) and illness understanding (BIPQ)) pre- and post-therapy. Results: At group level, emotion processing improved following therapy (p = .049). Some measures of clinical symptomology also improved, namely health-related quality of life (p = .02) and illness understanding (p = .01). Improvements in the EPS-25 correlated with improvements in mental health-related quality of life and psychological distress. Conclusions: Emotion processing and some measures of clinical symptomology improved in patients with FNS following BAPIT. The EPS-25 demonstrated changes that correlated with previously validated outcome measures. The EPS-25 is a suitable measure of psychotherapy-associated change in the FNS patient population.

30 January 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
IWIsobel Williams
Isobel Williams
PMPaul Graham Morris
Paul Graham Morris
MMMonica McCowat
Monica McCowat
DGDavid Gillespie
David Gillespie
Illness representations refer to a person's beliefs about their health condition and are thought to influence clinical outcomes. By understanding factors related to illness representations, potentially modifiable targets for psychological intervention can be identified. The aim of this systematic review was to synthesise the literature on factors associated with illness representations in people with epilepsy and functional seizures. Three electronic databases (Psychinfo, EMBASE, and Proquest (Theses and dissertations)) were searched for studies that reported on associations between Illness Perception Questionnaire scores (or variations thereof) and biopsychosocial factors in people with epilepsy or people with functional seizures. Seventeen studies met inclusion criteria and were assessed with a bespoke quality appraisal tool. Overall, there was moderately strong evidence for an association between more threatening illness representations and poorer clinical outcomes relating to seizure characteristics, distress, coping, and quality of life; the evidence for these relationships was stronger for people with epilepsy than functional seizures. There was no clear difference between the illness representations of the two groups. The results of this review highlight the clinical importance of illness representations in people with seizure disorders, as well as opportunities for further research.